Industry headlines are constantly buzzing with M&A activity and Healthtech VC investment trends.
On this episode of Diagnosing Healthtech, Jeff Englander (Healthcare Strategist) and Redox’s Sarah Bottjen (Director of Sales Enablement) delve into these topics in an interview with HSBC Innovation Banking’s Chris Moniz.
In addition to his role as Managing Director, Chris is a contributing author to HSBC Innovation Banking’s 1H 2023 Venture Healthcare Report, which combines analytics and expertise to provide industry perspectives and actionable insight to companies and investors.
Related Posts

Achieving inclusive real-world data and enabling access to care with Reagan-Udall’s Susan Winckler & Carla Rodriguez-Watson on Diagnosing Healthtech
https://www.youtube.com/watch?v=rD44LBgfl98 No matter how much health data you collect, it’s only valuable if it’s inclusive of entire affected…